Cognizant (CTSH) director logs 3,000-share sale under Rule 10b5-1 plan
Rhea-AI Filing Summary
Cognizant Technology Solutions Corp. director Michael Patsalos-Fox reported a planned sale of company stock. On 12/15/2025, he sold 3,000 shares of Class A common stock at a weighted average price of $83.8571, with individual trades executed between $83.38 and $84.50. The transaction was carried out under a Rule 10b5-1 trading plan adopted on September 11, 2025. Following this sale, he beneficially owns 44,729 shares directly and 6,775 shares indirectly through PFOXFAMILY LLC, whose membership interests are held by a trust for his children, with his spouse serving as co-trustee.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Cognizant (CTSH) disclose in this Form 4?
The filing reports that director Michael Patsalos-Fox sold 3,000 shares of Cognizant Technology Solutions Corp. Class A common stock on 12/15/2025.
At what price were the CTSH shares sold by the director?
The shares were sold at a weighted average price of $83.8571, with individual sale prices ranging from $83.38 to $84.50, inclusive.
Was the Cognizant (CTSH) insider sale under a Rule 10b5-1 plan?
Yes. The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
How many CTSH shares does the director own after this transaction?
After the transaction, the director beneficially owns 44,729 Cognizant Class A shares directly and 6,775 shares indirectly through PFOXFAMILY LLC.
What is PFOXFAMILY LLC’s relationship to the Cognizant (CTSH) director?
All membership interests of PFOXFAMILY LLC are held by a trust for the benefit of the director’s children, and the director’s spouse is a co-trustee of that trust.
What is the reporting person’s role at Cognizant Technology Solutions Corp. (CTSH)?
The reporting person is identified as a Director of Cognizant Technology Solutions Corp.